Sphera Funds Management as of June 30, 2014
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 100 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Novartis (NVS) | 11.9 | $48M | 533k | 90.55 | |
| Merck & Co (MRK) | 6.1 | $25M | 430k | 57.85 | |
| Teva Pharmaceutical Industries (TEVA) | 5.7 | $23M | 445k | 52.42 | |
| Johnson & Johnson (JNJ) | 5.5 | $22M | 214k | 104.62 | |
| Pfizer (PFE) | 4.8 | $19M | 655k | 29.68 | |
| GlaxoSmithKline | 4.0 | $16M | 300k | 53.48 | |
| Shire | 3.5 | $14M | 180k | 78.14 | |
| Sanofi-Aventis SA (SNY) | 3.1 | $13M | 120k | 106.22 | |
| Seattle Genetics | 2.8 | $11M | 298k | 38.25 | |
| BioMarin Pharmaceutical (BMRN) | 1.8 | $7.5M | 120k | 62.21 | |
| Biogen Idec (BIIB) | 1.7 | $6.9M | 22k | 315.32 | |
| Allergan Inc Com Stk | 1.7 | $6.8M | 40k | 169.22 | |
| Verint Systems (VRNT) | 1.6 | $6.6M | 135k | 49.05 | |
| Dyax | 1.5 | $6.2M | 650k | 9.60 | |
| Eli Lilly & Co. (LLY) | 1.5 | $6.2M | 100k | 62.17 | |
| AVANIR Pharmaceuticals | 1.4 | $5.6M | 1.0M | 5.64 | |
| Medivation | 1.3 | $5.4M | 70k | 77.09 | |
| Orbotech Ltd Com Stk | 1.3 | $5.2M | 344k | 15.18 | |
| Acorda Therapeutics | 1.2 | $5.1M | 150k | 33.71 | |
| Amgen | 1.2 | $4.7M | 40k | 118.38 | |
| B Communications (BCOMF) | 1.2 | $4.7M | 242k | 19.48 | |
| Yum! Brands (YUM) | 1.1 | $4.6M | 56k | 81.19 | |
| CSX Corporation (CSX) | 1.1 | $4.6M | 148k | 30.81 | |
| Walgreen Company | 1.1 | $4.5M | 61k | 74.12 | |
| Pharmacyclics | 1.1 | $4.5M | 50k | 89.72 | |
| Towers Watson & Co | 1.1 | $4.4M | 42k | 104.24 | |
| Clovis Oncology | 1.1 | $4.3M | 105k | 41.41 | |
| Gilead Sciences (GILD) | 1.0 | $4.1M | 50k | 82.92 | |
| Incyte Corporation (INCY) | 1.0 | $4.1M | 73k | 56.44 | |
| Ptc Therapeutics I (PTCT) | 1.0 | $3.9M | 150k | 26.14 | |
| Epizyme | 0.9 | $3.5M | 113k | 31.12 | |
| Colgate-Palmolive Company (CL) | 0.8 | $3.3M | 48k | 68.18 | |
| AutoNation (AN) | 0.8 | $3.1M | 53k | 59.68 | |
| Broadcom Corporation | 0.7 | $2.9M | 79k | 37.12 | |
| Caesar Stone Sdot Yam (CSTE) | 0.7 | $2.9M | 60k | 49.08 | |
| Aerie Pharmaceuticals | 0.7 | $2.7M | 110k | 24.77 | |
| Tetraphase Pharmaceuticals | 0.7 | $2.7M | 198k | 13.49 | |
| Ampio Pharmaceuticals | 0.6 | $2.6M | 312k | 8.35 | |
| Google Inc Class C | 0.6 | $2.6M | 4.5k | 575.33 | |
| Receptos | 0.6 | $2.6M | 60k | 42.60 | |
| Oncothyreon | 0.6 | $2.4M | 738k | 3.24 | |
| Macrogenics (MGNX) | 0.6 | $2.4M | 111k | 21.73 | |
| Celladon | 0.6 | $2.4M | 150k | 16.02 | |
| priceline.com Incorporated | 0.6 | $2.3M | 1.9k | 1202.90 | |
| Gilead Sciences Inc option | 0.6 | $2.3M | 2.0k | 1158.00 | |
| Vanda Pharmaceuticals (VNDA) | 0.6 | $2.3M | 140k | 16.18 | |
| 0.5 | $2.2M | 3.8k | 584.57 | ||
| Actinium Pharmaceuticals | 0.5 | $2.2M | 300k | 7.22 | |
| Akebia Therapeutics (AKBA) | 0.5 | $2.0M | 73k | 27.79 | |
| Immunomedics | 0.5 | $2.0M | 550k | 3.65 | |
| Vertex Pharmaceuticals Inc option | 0.5 | $1.9M | 1.0k | 1905.00 | |
| Ambit Bioscience | 0.5 | $1.9M | 278k | 6.91 | |
| Trevena | 0.5 | $1.9M | 341k | 5.65 | |
| Ignyta | 0.5 | $1.9M | 205k | 9.09 | |
| Health Care SPDR (XLV) | 0.4 | $1.8M | 29k | 60.85 | |
| Aquinox Pharmaceuticals | 0.4 | $1.8M | 190k | 9.37 | |
| Oncomed Pharmaceuticals | 0.4 | $1.7M | 75k | 23.31 | |
| Cytrx | 0.4 | $1.7M | 400k | 4.18 | |
| Puma Biotechnology (PBYI) | 0.4 | $1.7M | 25k | 66.00 | |
| Galmed Pharmaceuticals | 0.4 | $1.7M | 170k | 9.74 | |
| NPS Pharmaceuticals | 0.4 | $1.6M | 49k | 33.04 | |
| Insmed (INSM) | 0.4 | $1.6M | 79k | 19.97 | |
| Prosensa Hldgs B V Shs Usd | 0.4 | $1.6M | 125k | 12.62 | |
| Intra Cellular Therapies (ITCI) | 0.4 | $1.6M | 94k | 16.86 | |
| Teva Pharmaceutical Inds Ltd option | 0.4 | $1.6M | 3.2k | 485.00 | |
| CVS Caremark Corporation (CVS) | 0.4 | $1.5M | 19k | 75.36 | |
| Penske Automotive (PAG) | 0.4 | $1.5M | 29k | 49.51 | |
| Genvec | 0.4 | $1.5M | 575k | 2.57 | |
| Arrowhead Resh | 0.3 | $1.4M | 100k | 14.31 | |
| TJX Companies (TJX) | 0.3 | $1.4M | 26k | 53.13 | |
| Sonic Automotive (SAH) | 0.3 | $1.3M | 50k | 26.68 | |
| Array BioPharma | 0.3 | $1.3M | 285k | 4.56 | |
| Biolinerx Ltd-spons | 0.3 | $1.2M | 600k | 2.08 | |
| Tetrelogic Pharmaceuticals (TLOG) | 0.3 | $1.2M | 200k | 5.89 | |
| Achillion Pharmaceuticals | 0.3 | $1.1M | 150k | 7.57 | |
| Amgen | 0.3 | $1.1M | 1.2k | 904.68 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $1.1M | 25k | 45.84 | |
| INSTRS INC Stemcells | 0.2 | $1.0M | 500k | 2.03 | |
| Ocera Therapeutics | 0.2 | $971k | 127k | 7.64 | |
| Salix Pharmaceuticals Inc option | 0.2 | $915k | 500.00 | 1830.00 | |
| Dipexium Pharmaceuticals | 0.2 | $916k | 94k | 9.70 | |
| Discovery Laboratories | 0.2 | $890k | 500k | 1.78 | |
| Kalobios Pharmaceuticals | 0.2 | $821k | 360k | 2.28 | |
| Glaxosmithkline | 0.2 | $698k | 3.0k | 232.67 | |
| Ormat Technologies (ORA) | 0.2 | $677k | 24k | 28.84 | |
| Impax Laboratories Inc Cmn Stock cmn | 0.1 | $550k | 1.0k | 550.00 | |
| Tg Therapeutics (TGTX) | 0.1 | $563k | 60k | 9.38 | |
| Rxi Pharmaceuticals | 0.1 | $531k | 176k | 3.02 | |
| Corium Intl | 0.1 | $537k | 69k | 7.77 | |
| Summit Financial | 0.1 | $455k | 777.00 | 585.59 | |
| Spdr S&p 500 Etf Tr option | 0.1 | $338k | 1.5k | 225.33 | |
| Cytokinetics (CYTK) | 0.1 | $311k | 65k | 4.78 | |
| Insmed | 0.1 | $293k | 1.0k | 293.00 | |
| Ellomay Capital (ELLO) | 0.1 | $192k | 21k | 9.34 | |
| Teva Pharmaceutical Inds Ltd option | 0.0 | $80k | 1.0k | 80.00 | |
| Tjx Cos | 0.0 | $69k | 500.00 | 138.00 | |
| Top Image Systems Ltd ord | 0.0 | $79k | 20k | 3.95 | |
| Auxilium Pharmaceuticals Inc option | 0.0 | $40k | 935.00 | 42.78 | |
| VERTEX PHARMACEUTICALS INC CMN Stk cmn | 0.0 | $13k | 1.5k | 8.67 | |
| Lumenis Ltd shs cl b | 0.0 | $0 | 245.00 | 0.00 |
